These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

622 related items for PubMed ID: 20182376

  • 1. Rapid and selective enzymatic debridement of porcine comb burns with bromelain-derived Debrase: acute-phase preservation of noninjured tissue and zone of stasis.
    Singer AJ, McClain SA, Taira BR, Rooney J, Steinhauff N, Rosenberg L.
    J Burn Care Res; 2010; 31(2):304-9. PubMed ID: 20182376
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Reepithelialization of mid-dermal porcine burns after rapid enzymatic debridement with Debrase®.
    Singer AJ, Taira BR, Anderson R, McClain SA, Rosenberg L.
    J Burn Care Res; 2011; 32(6):647-53. PubMed ID: 21979853
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Selectivity of a bromelain based enzymatic debridement agent: a porcine study.
    Rosenberg L, Krieger Y, Silberstein E, Arnon O, Sinelnikov IA, Bogdanov-Berezovsky A, Singer AJ.
    Burns; 2012 Nov; 38(7):1035-40. PubMed ID: 22385643
    [Abstract] [Full Text] [Related]

  • 7. Curcumin reduces injury progression in a rat comb burn model.
    Singer AJ, Taira BR, Lin F, Lim T, Anderson R, McClain SA, Clark RA.
    J Burn Care Res; 2011 Nov; 32(1):135-42. PubMed ID: 21088615
    [Abstract] [Full Text] [Related]

  • 8. Rosiglitazone, a PPAR-gamma ligand, reduces burn progression in rats.
    Taira BR, Singer AJ, McClain SA, Lin F, Rooney J, Zimmerman T, Clark RA.
    J Burn Care Res; 2009 Nov; 30(3):499-504. PubMed ID: 19349877
    [Abstract] [Full Text] [Related]

  • 9. Immediate burn excision fails to reduce injury progression.
    Macri LK, Singer AJ, Taira BR, McClain SA, Rosenberg L, Clark RA.
    J Burn Care Res; 2013 Nov; 34(3):e153-60. PubMed ID: 23624996
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A novel rapid and selective enzymatic debridement agent for burn wound management: a multi-center RCT.
    Rosenberg L, Krieger Y, Bogdanov-Berezovski A, Silberstein E, Shoham Y, Singer AJ.
    Burns; 2014 May; 40(3):466-74. PubMed ID: 24074719
    [Abstract] [Full Text] [Related]

  • 12. [Effects of early debridement and conservative eschar removal followed by wound coverage with acellular dermal matrix in the treatment of children with deep burns].
    Liang Y, Shi W, Shao Y, Liu XZ, Gong HM, Cao GH, Gao C, Xin NJ, Song GD.
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2024 Apr 20; 40(4):348-357. PubMed ID: 38664029
    [Abstract] [Full Text] [Related]

  • 13. A Comparison of Topical Agents for Eschar Removal in a Porcine Model: Bromelain-enriched vs Traditional Collagenase Agents.
    Singer AJ, Goradia EN, Grandfield S, Zhang N, Shah K, McClain SA, Sandoval S, Shoham Y.
    J Burn Care Res; 2023 Mar 02; 44(2):408-413. PubMed ID: 35764058
    [Abstract] [Full Text] [Related]

  • 14. Effect of tadalafil on reduction of necrosis in the ischemic zone in a rat comb burn model.
    Singer AJ, Towery H, McClain SA.
    Burns; 2018 Sep 02; 44(6):1427-1432. PubMed ID: 29895403
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Role of Necroptosis in Burn Injury Progression in a Rat Comb Burn Model.
    Reddy AS, Abraham A, McClain SA, Clark RA, Ralen P, Sandoval S, Singer AJ.
    Acad Emerg Med; 2015 Oct 02; 22(10):1181-6. PubMed ID: 26375585
    [Abstract] [Full Text] [Related]

  • 17. Enzymatic debridement of deeply burned faces: Healing and early scarring based on tissue preservation compared to traditional surgical debridement.
    Schulz A, Fuchs PC, Rothermundt I, Hoffmann A, Rosenberg L, Shoham Y, Oberländer H, Schiefer J.
    Burns; 2017 Sep 02; 43(6):1233-1243. PubMed ID: 28363663
    [Abstract] [Full Text] [Related]

  • 18. A Retrospective Review of an Off-label Bromelain-based Selective Enzymatic Debridement (Nexobrid®) in the Treatment of Deep, Partial, and Full Thickness Burns and Hard to Heal Wounds.
    Harats M, Haik J, Cleary M, Vashurin I, Aviv U, Kornhaber R.
    Isr Med Assoc J; 2020 Feb 02; 22(2):83-88. PubMed ID: 32043324
    [Abstract] [Full Text] [Related]

  • 19. Eschar removal by bromelain based enzymatic debridement (Nexobrid®) in burns: An European consensus.
    Hirche C, Citterio A, Hoeksema H, Koller J, Lehner M, Martinez JR, Monstrey S, Murray A, Plock JA, Sander F, Schulz A, Ziegler B, Kneser U.
    Burns; 2017 Dec 02; 43(8):1640-1653. PubMed ID: 29033046
    [Abstract] [Full Text] [Related]

  • 20. Combined ultrasonic and enzymatic debridement of necrotic eschars in an animal model.
    Gurfinkel R, Lavon I, Cagnano E, Volgin K, Shaltiel L, Grossman N, Kost J, Singer AJ, Rosenberg L.
    J Burn Care Res; 2009 Dec 02; 30(3):505-13. PubMed ID: 19349883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.